ALPS Medical Breakthroughs ETF
SBIO
23 hedge funds and large institutions have $13.9M invested in ALPS Medical Breakthroughs ETF in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 14 reducing their positions, and 9 closing their positions.
4.09% less ownership
Funds ownership: 18.64% → 14.55% (-4.1%)
26% less funds holding
Funds holding: 31 → 23 (-8)
55% less capital invested
Capital invested by funds: $31M → $13.9M (-$17.1M)
64% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 14
89% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 9
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$3.96M |
| 2 |
IA
IFP Advisors
Tampa,
Florida
|
+$159K |
| 3 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$39.1K |
| 4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$36K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$35.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPL Financial
San Diego,
California
|
-$9.5M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$875K |
| 3 |
MCM
Murphy Capital Management
Bedminster,
New Jersey
|
-$439K |
| 4 |
SWP
Stratos Wealth Partners
Beachwood,
Ohio
|
-$394K |
| 5 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
-$363K |
SBIO Hedge Fund Activity: Q1 2016 in Review
23 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q1 2016, worth a combined $13.9M — down 55% from $31M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of SBIO and 1 opened new positions — a net loss of 8 holders — while 14 trimmed existing stakes and 5 added.
The largest buyer was Morgan Stanley, adding an estimated $3.96M. The largest seller was LPL Financial, cutting an estimated $9.5M.
- 23 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q1 2016, down from 31 in Q4 2015.
- Funds reported $13.9M of ALPS Medical Breakthroughs ETF stock for Q1 2016, down 55% quarter-over-quarter.
- 1 fund opened new ALPS Medical Breakthroughs ETF positions in Q1 2016 and 9 closed out, a net change of -8 holders.
- The largest ALPS Medical Breakthroughs ETF buyer in Q1 2016 was Morgan Stanley, an estimated $3.96M added.
- The largest ALPS Medical Breakthroughs ETF seller in Q1 2016 was LPL Financial, an estimated $9.5M sold.
Based on aggregated 13F filings for Q1 2016.